Skip to main content
OpenTrials

Clinical trial condition

Multiple Sclerosis

Explore clinical trials studying Multiple Sclerosis. Study availability and eligibility vary by location and protocol.

2,414 public trials 350 recruiting studies
Refine in advanced search Browse all conditions

Multiple Sclerosis trial results

Recruiting

A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)

NCT06433752

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
Locations
  • TG Therapeutics Investigational Trial Site Birmingham, Alabama, United States
  • TG Therapeutics Investigational Trial Site Huntsville, Alabama, United States
  • TG Therapeutics Investigational Trial Site Mobile, Alabama, United States
  • TG Therapeutics Investigational Trial Site Gilbert, Arizona, United States
View all 111 locations
View Trial Details
Recruiting

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

NCT03816345

Conditions
Arthritis, Arthritis, Psoriatic, Arthritis, Rheumatoid, +59 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Stanford Cancer Institute Palo Alto Palo Alto, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
  • Smilow Cancer Center/Yale-New Haven Hospital New Haven, Connecticut, United States
View all 52 locations
View Trial Details
Recruiting

Treatment of Participants With Primary or Secondary Progressive Multiple Sclerosis

NCT07477639

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +13 more
Locations
  • University of Kansas Medical Center Kansas City, Kansas, United States
  • Washington University, St. Louis St Louis, Missouri, United States
  • UC San Diego La Jolla, California, United States
  • Mayo Clinic Rochester, Minnesota, United States
View Trial Details
Recruiting

A Study to Evaluate Pharmacokinetics (PK) and Safety of Subcutaneous (SC) Ublituximab Administered at Various Injection Sites and Relative Bioavailability Via Autoinjector (AI) Versus Syringe Subcutaneously in Participants With Multiple Sclerosis (MS)

NCT07503873

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations
  • TG Therapeutics Investigational Trial Site Bihać, Bosnia and Herzegovina
  • TG Therapeutics Investigational Trial Site Sarajevo, Bosnia and Herzegovina
  • TG Therapeutics Investigational Trial Site Tuzla, Bosnia and Herzegovina
  • TG Therapeutics Investigational Trial Site Zenica, Bosnia and Herzegovina
View all 39 locations
View Trial Details

Related conditions